{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:21:26Z","timestamp":1787613686664,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":75,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57020-4","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:06:04Z","timestamp":1781132764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["GMMA as delivery system for Klebsiella pneumoniae O-antigens and K-antigens"],"prefix":"10.1038","volume":"16","author":[{"given":"Maria Michelina","family":"Raso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Nappini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Gnoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Aruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Molfetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Arato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Cescutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Carducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Alfini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Giannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Micoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Gasperini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"57020_CR1","unstructured":"World Health Organization. Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery and Development of New Antibiotics. 2017. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"issue":"19 Suppl 1","key":"57020_CR2","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1016\/j.vaccine.2024.02.072","volume":"42","author":"Z Dangor","year":"2024","unstructured":"Dangor, Z. et al. Vaccine value profile for Klebsiella pneumoniae. Vaccine 42(19 Suppl 1), S125-s141. https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.072 (2024).","journal-title":"Vaccine"},{"issue":"7","key":"57020_CR3","doi-asserted-by":"publisher","first-page":"e909","DOI":"10.1016\/s2214-109x(20)30205-9","volume":"8","author":"AW Taylor","year":"2020","unstructured":"Taylor, A. W. Initial findings from a novel population-based child mortality surveillance approach: A descriptive study. Lancet Glob. Health 8(7), e909\u2013e919. https:\/\/doi.org\/10.1016\/s2214-109x(20)30205-9 (2020).","journal-title":"Lancet Glob. Health"},{"issue":"4","key":"57020_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/s41564-021-00870-7","volume":"6","author":"K Sands","year":"2021","unstructured":"Sands, K. Characterization of antimicrobial-resistant gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries. Nat. Microbiol. 6(4), 512\u2013523. https:\/\/doi.org\/10.1038\/s41564-021-00870-7 (2021).","journal-title":"Nat. Microbiol."},{"issue":"7","key":"57020_CR5","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1080\/14760584.2019.1635460","volume":"18","author":"M Choi","year":"2019","unstructured":"Choi, M. Progress towards the development of Klebsiella vaccines. Expert Rev. Vaccines 18(7), 681\u2013691. https:\/\/doi.org\/10.1080\/14760584.2019.1635460 (2019).","journal-title":"Expert Rev. Vaccines"},{"key":"57020_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22084042","author":"V Arato","year":"2021","unstructured":"Arato, V., Raso, M. M., Gasperini, G., Berlanda Scorza, F. & Micoli, F. Prophylaxis and treatment against Klebsiella pneumoniae: Current insights on this emerging anti-microbial resistant global threat. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22084042 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"57020_CR7","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000073","volume":"2","author":"R Follador","year":"2016","unstructured":"Follador, R. et al. The diversity of Klebsiella pneumoniae surface polysaccharides. Microb. Genom. 2(8), e000073. https:\/\/doi.org\/10.1099\/mgen.0.000073 (2016).","journal-title":"Microb. Genom."},{"key":"57020_CR8","doi-asserted-by":"publisher","DOI":"10.1099\/mgen.0.000800","author":"MMC Lam","year":"2022","unstructured":"Lam, M. M. C., Wick, R. R., Judd, L. M., Holt, K. E. & Wyres, K. L. Kaptive 2.0: Updated capsule and lipopolysaccharide locus typing for the Klebsiella pneumoniae species complex. Microbial. Genomics https:\/\/doi.org\/10.1099\/mgen.0.000800 (2022).","journal-title":"Microbial. Genomics"},{"issue":"4","key":"57020_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012971","volume":"21","author":"J Le Bris","year":"2025","unstructured":"Le Bris, J., Chen, N., Supandy, A., Rendueles, O. & Van Tyne, D. Phage therapy for Klebsiella pneumoniae: Understanding bacteria\u2013phage interactions for therapeutic innovations. PLoS Pathog. 21(4), e1012971. https:\/\/doi.org\/10.1371\/journal.ppat.1012971 (2025).","journal-title":"PLoS Pathog."},{"key":"57020_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/2025.06.28.25330253","author":"TD Stanton","year":"2025","unstructured":"Stanton, T. D. et al. Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: Meta-analysis of genome-predicted serotype prevalence and potential vaccine coverage. medRxiv https:\/\/doi.org\/10.1101\/2025.06.28.25330253 (2025).","journal-title":"medRxiv"},{"key":"57020_CR11","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fmicb.2014.00608FromNLM","volume":"5","author":"PF Hsieh","year":"2014","unstructured":"Hsieh, P. F. et al. D-galactan II is an immunodominant antigen in O1 lipopolysaccharide and affects virulence in Klebsiella pneumoniae: Implication in vaccine design. Front. Microbiol. 5, 608. https:\/\/doi.org\/10.3389\/fmicb.2014.00608FromNLM (2014).","journal-title":"Front. Microbiol."},{"issue":"3","key":"57020_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1159\/000518679FromNLM","volume":"14","author":"C Opoku-Temeng","year":"2022","unstructured":"Opoku-Temeng, C., Malachowa, N., Kobayashi, S. D. & DeLeo, F. R. Innate Host defense against klebsiella pneumoniae and the outlook for Development of immunotherapies. J. Innate Immun. 14(3), 167\u2013181. https:\/\/doi.org\/10.1159\/000518679FromNLM (2022).","journal-title":"J. Innate Immun."},{"issue":"3","key":"57020_CR13","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1093\/infdis\/jiae097FromNLM","volume":"230","author":"PL Wantuch","year":"2024","unstructured":"Wantuch, P. L. et al. Heptavalent O-antigen bioconjugate vaccine exhibiting differential functional antibody responses against diverse klebsiella pneumoniae isolates. J. Infect. Dis. 230(3), 578\u2013589. https:\/\/doi.org\/10.1093\/infdis\/jiae097FromNLM (2024).","journal-title":"J. Infect. Dis."},{"issue":"6","key":"57020_CR14","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1128\/iai.60.6.2529-2535.1992FromNLM","volume":"60","author":"S Merino","year":"1992","unstructured":"Merino, S., Camprub\u00ed, S., Albert\u00ed, S., Bened\u00ed, V. J. & Tom\u00e1s, J. M. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect. Immun. 60(6), 2529\u20132535. https:\/\/doi.org\/10.1128\/iai.60.6.2529-2535.1992FromNLM (1992).","journal-title":"Infect. Immun."},{"key":"57020_CR15","doi-asserted-by":"publisher","unstructured":"Hwang, W.; Wantuch, P. L.; Bernshtein, B.; Zhiteneva, J.; Slater, D.; Vater, K. H.; Sridhar, S.; Oliver, E.; Roach, D. J.; Rao, S.; et al. Antibody responses in Klebsiella pneumoniae bloodstream infection: a cohort study. bioRxiv: the preprint server for biology 2024. https:\/\/doi.org\/10.1101\/2024.05.01.591958","DOI":"10.1101\/2024.05.01.591958"},{"issue":"5","key":"57020_CR16","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1128\/iai.65.5.1754-1760.1997FromNLM","volume":"65","author":"T Rukavina","year":"1997","unstructured":"Rukavina, T. et al. Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection. Infect. Immun. 65(5), 1754\u20131760. https:\/\/doi.org\/10.1128\/iai.65.5.1754-1760.1997FromNLM (1997).","journal-title":"Infect. Immun."},{"issue":"5","key":"57020_CR17","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41591-020-0825-4FromNLM","volume":"26","author":"CM Ernst","year":"2020","unstructured":"Ernst, C. M. et al. Adaptive evolution of virulence and persistence in carbapenem-resistant Klebsiella pneumoniae. Nat. Med. 26(5), 705\u2013711. https:\/\/doi.org\/10.1038\/s41591-020-0825-4FromNLM (2020).","journal-title":"Nat. Med."},{"key":"57020_CR18","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.mib.2020.01.006FromNLM","volume":"54","author":"KA Walker","year":"2020","unstructured":"Walker, K. A. & Miller, V. L. The intersection of capsule gene expression, hypermucoviscosity and hypervirulence in Klebsiella pneumoniae. Curr. Opin. Microbiol. 54, 95\u2013102. https:\/\/doi.org\/10.1016\/j.mib.2020.01.006FromNLM (2020).","journal-title":"Curr. Opin. Microbiol."},{"issue":"1","key":"57020_CR19","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/s42003-025-08258-7","volume":"8","author":"F Nonne","year":"2025","unstructured":"Nonne, F. et al. The characterization of Klebsiella pneumoniae associated with neonatal sepsis in low- and middle-income countries to inform vaccine design. Commun. Biol. 8(1), 898. https:\/\/doi.org\/10.1038\/s42003-025-08258-7 (2025).","journal-title":"Commun. Biol."},{"key":"57020_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.715393FromNLM","volume":"12","author":"F Mancini","year":"2021","unstructured":"Mancini, F. et al. GMMA-based vaccines: The known and the unknown. Front. Immunol. 12, 715393. https:\/\/doi.org\/10.3389\/fimmu.2021.715393FromNLM (2021).","journal-title":"Front. Immunol."},{"key":"57020_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031309","author":"G Gasperini","year":"2021","unstructured":"Gasperini, G. Effect of O-antigen chain length regulation on the immunogenicity of Shigella and Salmonella generalized modules for membrane antigens (GMMA). Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms22031309 (2021).","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"57020_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134478","volume":"10","author":"C Gerke","year":"2015","unstructured":"Gerke, C. et al. Production of a Shigella sonnei vaccine based on generalized modules for membrane antigens (GMMA), 1790GAHB. PLoS ONE 10(8), e0134478. https:\/\/doi.org\/10.1371\/journal.pone.0134478 (2015).","journal-title":"PLoS ONE"},{"issue":"6","key":"57020_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035616","volume":"7","author":"F Berlanda Scorza","year":"2012","unstructured":"Berlanda Scorza, F. et al. High yield production process for Shigella outer membrane particles. PLoS ONE 7(6), e35616. https:\/\/doi.org\/10.1371\/journal.pone.0035616 (2012).","journal-title":"PLoS ONE"},{"issue":"4","key":"57020_CR24","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3390\/biology13040256","volume":"13","author":"F Nonne","year":"2024","unstructured":"Nonne, F. et al. Development and application of a high-throughput method for the purification and analysis of surface carbohydrates from klebsiella pneumoniae. Biology 13(4), 256 (2024).","journal-title":"Biology"},{"issue":"1","key":"57020_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1038\/s41541-023-00725-8FromNLM","volume":"8","author":"O Rossi","year":"2023","unstructured":"Rossi, O. et al. A next-generation GMMA-based vaccine candidate to fight shigellosis. NPJ. Vaccines 8(1), 130. https:\/\/doi.org\/10.1038\/s41541-023-00725-8FromNLM (2023).","journal-title":"NPJ. Vaccines"},{"key":"57020_CR26","doi-asserted-by":"publisher","first-page":"1347813","DOI":"10.3389\/fcimb.2024.1347813FromNLM","volume":"14","author":"G Gasperini","year":"2024","unstructured":"Gasperini, G. et al. O-Antigen decorations in Salmonella enterica play a key role in eliciting functional immune responses against heterologous serovars in animal models. Front Cell Infect. Microbiol. 14, 1347813. https:\/\/doi.org\/10.3389\/fcimb.2024.1347813FromNLM (2024).","journal-title":"Front Cell Infect. Microbiol."},{"key":"57020_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.105903FromNLM","volume":"119","author":"B Hanumunthadu","year":"2025","unstructured":"Hanumunthadu, B. et al. Safety and immunogenicity of the invasive non-typhoidal Salmonella (iNTS)-GMMA vaccine: a first-in-human, randomised, dose escalation trial. EBioMedicine 119, 105903. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105903FromNLM (2025).","journal-title":"EBioMedicine"},{"issue":"3","key":"57020_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004749","volume":"11","author":"M Caboni","year":"2015","unstructured":"Caboni, M. et al. An O antigen capsule modulates bacterial pathogenesis in Shigella sonnei. PLoS Pathog. 11(3), e1004749. https:\/\/doi.org\/10.1371\/journal.ppat.1004749 (2015).","journal-title":"PLoS Pathog."},{"key":"57020_CR29","doi-asserted-by":"publisher","DOI":"10.1128\/iai.00699-20","author":"G Gasperini","year":"2021","unstructured":"Gasperini, G. et al. Salmonella Paratyphi A outer membrane vesicles displaying VI polysaccharide as a multivalent vaccine against enteric fever. Infect. Immun. https:\/\/doi.org\/10.1128\/iai.00699-20 (2021).","journal-title":"Infect. Immun."},{"issue":"5","key":"57020_CR30","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.str.2013.03.010","volume":"21","author":"SR Bushell","year":"2013","unstructured":"Bushell, S. R. Wzi is an outer membrane lectin that underpins group 1 capsule assembly in Escherichia coli. Structure 21(5), 844\u2013853. https:\/\/doi.org\/10.1016\/j.str.2013.03.010 (2013).","journal-title":"Structure"},{"issue":"23","key":"57020_CR31","doi-asserted-by":"publisher","first-page":"7515","DOI":"10.1128\/jb.175.23.7515-7522.1993","volume":"175","author":"PR MacLachlan","year":"1993","unstructured":"MacLachlan, P. R., Keenleyside, W. J., Dodgson, C. & Whitfield, C. Formation of the K30 (group I) capsule in Escherichia coli O9:K30 does not require attachment to lipopolysaccharide lipid A-core. J. Bacteriol. 175(23), 7515\u20137522. https:\/\/doi.org\/10.1128\/jb.175.23.7515-7522.1993 (1993).","journal-title":"J. Bacteriol."},{"issue":"1","key":"57020_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41541-022-00497-7FromNLM","volume":"7","author":"G Gasperini","year":"2022","unstructured":"Gasperini, G. et al. Rapid generation of Shigella flexneri GMMA displaying natural or new and cross-reactive O-Antigens. NPJ. Vaccines 7(1), 69. https:\/\/doi.org\/10.1038\/s41541-022-00497-7FromNLM (2022).","journal-title":"NPJ. Vaccines"},{"issue":"2","key":"57020_CR33","doi-asserted-by":"publisher","DOI":"10.1128\/msphere.00680-22","volume":"8","author":"HR Wagstaffe","year":"2023","unstructured":"Wagstaffe, H. R. The development of immunological assays to evaluate the level and function of antibodies induced by Klebsiella pneumoniae O-antigen vaccines. mSphere 8(2), e0068022. https:\/\/doi.org\/10.1128\/msphere.00680-22 (2023).","journal-title":"mSphere"},{"key":"57020_CR34","doi-asserted-by":"publisher","unstructured":"Hwang, W.; Wantuch, P. L.; Bernshtein, B.; Zhiteneva, J.; Slater, D.; Vater, K. H.; Sridhar, S.; Oliver, E.; Roach, D. J.; Rao, S.; et al. Antibody responses in Klebsiella pneumoniae bloodstream infection: a cohort study. 2024, 2024.2005.2001.591958. https:\/\/doi.org\/10.1101\/2024.05.01.591958","DOI":"10.1101\/2024.05.01.591958"},{"issue":"1","key":"57020_CR35","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1038\/s41598-020-80421-y","volume":"11","author":"F Mancini","year":"2021","unstructured":"Mancini, F. et al. Dissecting the contribution of O-antigen and proteins to the immunogenicity of Shigella sonnei generalized modules for membrane antigens (GMMA). Sci. Rep. 11(1), 906. https:\/\/doi.org\/10.1038\/s41598-020-80421-y (2021).","journal-title":"Sci. Rep."},{"key":"57020_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13030226","author":"Q Ou","year":"2025","unstructured":"Ou, Q. Exploration of a GMMA-based bivalent vaccine against Klebsiella pneumoniae. Vaccines https:\/\/doi.org\/10.3390\/vaccines13030226 (2025).","journal-title":"Vaccines"},{"key":"57020_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8030540","author":"F Micoli","year":"2020","unstructured":"Micoli, F. GMMA is a versatile platform to design effective multivalent combination vaccines. Vaccines https:\/\/doi.org\/10.3390\/vaccines8030540 (2020).","journal-title":"Vaccines"},{"issue":"12","key":"57020_CR38","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1073\/pnas.120163297","volume":"97","author":"KA Datsenko","year":"2000","unstructured":"Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA 97(12), 6640\u20136645. https:\/\/doi.org\/10.1073\/pnas.120163297 (2000).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"57020_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8020160","author":"MM Raso","year":"2020","unstructured":"Raso, M. M. GMMA and glycoconjugate approaches compared in mice for the development of a vaccine against Shigella flexneri serotype 6. Vaccines https:\/\/doi.org\/10.3390\/vaccines8020160 (2020).","journal-title":"Vaccines"},{"issue":"11","key":"57020_CR40","doi-asserted-by":"publisher","first-page":"8282","DOI":"10.1021\/acsomega.7b01173FromNLM","volume":"2","author":"G De Benedetto","year":"2017","unstructured":"De Benedetto, G., Cescutti, P., Giannelli, C., Rizzo, R. & Micoli, F. Multiple techniques for size determination of generalized modules for membrane antigens from salmonella typhimurium and salmonella enteritidis. ACS Omega 2(11), 8282\u20138289. https:\/\/doi.org\/10.1021\/acsomega.7b01173FromNLM (2017).","journal-title":"ACS Omega"},{"key":"57020_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carres.2013.12.003FromNLM","volume":"385","author":"F Micoli","year":"2014","unstructured":"Micoli, F. et al. Structural analysis of O-polysaccharide chains extracted from different Salmonella Typhimurium strains. Carbohydr. Res. 385, 1\u20138. https:\/\/doi.org\/10.1016\/j.carres.2013.12.003FromNLM (2014).","journal-title":"Carbohydr. Res."},{"issue":"3","key":"57020_CR42","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.vaccine.2016.11.089","volume":"35","author":"G De Benedetto","year":"2017","unstructured":"De Benedetto, G. et al. Characterization of O-antigen delivered by generalized modules for membrane antigens (GMMA) vaccine candidates against nontyphoidal Salmonella. Vaccine 35(3), 419\u2013426. https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.089 (2017).","journal-title":"Vaccine"},{"key":"57020_CR43","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-0716-1900-1_14FromNLM","volume":"2414","author":"F Micoli","year":"2022","unstructured":"Micoli, F., Alfini, R. & Giannelli, C. Methods for assessment of OMV\/GMMA quality and stability. Methods Mol. Biol. 2414, 227\u2013279. https:\/\/doi.org\/10.1007\/978-1-0716-1900-1_14FromNLM (2022).","journal-title":"Methods Mol. Biol."},{"key":"57020_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jim.2018.06.025","volume":"461","author":"F Necchi","year":"2018","unstructured":"Necchi, F. Setup of luminescence-based serum bactericidal assay against Salmonella paratyphi A. J. Immunol. Methods 461, 117\u2013121. https:\/\/doi.org\/10.1016\/j.jim.2018.06.025 (2018).","journal-title":"J. Immunol. Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57020-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57020-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57020-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:42:12Z","timestamp":1787611332000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57020-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57020"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57020-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,11]]},"assertion":[{"value":"11 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was undertaken at the request of and sponsored by GlaxoSmithKline Biologicals SA. GSK Vaccines Institute for Global Health Srl is an affiliate of GlaxoSmithKline Biologicals SA. M.M.R., R.N., M.G.A., M.M., V.A., S.D., M.C., R.A., C.G., O.R., F.M., and G.G. are employees of the GSK group of companies.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26539"}}